Piloting At-birth Point of Care HIV Testing Strategies in Kenya

2018-02-21 19:15:12 | BioPortfolio

Published on BioPortfolio: 2018-02-21T19:15:12-0500

Clinical Trials [1367 Associated Clinical Trials listed on BioPortfolio]

Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children

This is a two-arm, unmasked, randomized, controlled trial to test the effectiveness of the Alere Q point-of-care (POC) HIV diagnostic assay for use in resource-poor settings.

Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand

Two new rapid HIV tests by Alere™ have the potential to substantially decrease the window period for rapid tests. First, the Alere™ HIV Combo is a rapid fourth generation test. The per...

Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

Randomised Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiret...

Early Infant Diagnosis Point of Care Pilot

In Mozambique, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories in Maputo, Nampula, B...

Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants

The purpose of the study is to test the effect of the Alere™ q HIV-1/2 Detect (diagnostic assay) on uptake of HIV testing among HIV-exposed infants and young children, and health outcome...

PubMed Articles [19930 Associated PubMed Articles listed on BioPortfolio]

Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.

The Alere q HIV-1/2 Detect test (Alere Detect) is a rapid point-of-care (POC) nucleic acid test (NAT) that can detect and differentiate HIV-1 and HIV-2 in 25-μL whole blood or plasma samples. The Ale...

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.

HIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. Gen...

Field evaluation of HIV point-of-care testing for early infant diagnosis in Cape Town, South Africa.

Early infant HIV diagnosis (EID) coverage and uptake remains challenging. Point-of-care (POC) testing may improve access and turn-around-times, but, while several POC technologies are in development t...

Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial.

We measured the effect of point-of-care early infant HIV testing on antiretroviral therapy initiation rates and retention in care among infants in Mozambique.

Improving the quality of point-of-care testing.

It is suggested that new models of primary care should have better access to test results through the use of point-of-care testing (POCT).

Medical and Biotech [MESH] Definitions

Allows patient diagnoses in the physician’s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)

Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry.

Purchasers are provided information on the quality of health care, including patient outcomes and health status, with data on the dollar outlays going towards health. The focus is on managing the use of the health care system to reduce inappropriate care and to identify and reward the best-performing providers. (from accessed 11/25/2011)

Care of infants in the home or institution.

Care of the newborn infant in a crib near the mother's bed, instead of in a nursery, during the hospital stay.

More From BioPortfolio on "Piloting At-birth Point of Care HIV Testing Strategies in Kenya"

Quick Search


Searches Linking to this Trial